Kymera Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC KYMR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

912,498

Value ($000)

71,001

Weight

0.0%

2021 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	71,001	0.0%	912,498	12/31/2025
2025 Q3	11/14/2025	48,889	0.0%	863,762	9/30/2025
2025 Q2	8/14/2025	35,738	0.0%	818,927	6/30/2025
2025 Q1	5/19/2025	24,535	0.0%	896,404	3/31/2025
2024 Q4	2/14/2025	16,280	0.0%	404,667	12/31/2024
2024 Q3	11/14/2024	20,282	0.0%	428,529	9/30/2024
2024 Q2	8/14/2024	12,942	0.0%	433,573	6/30/2024
2024 Q1	5/15/2024	7,234	0.0%	179,938	3/31/2024
2023 Q4	2/14/2024	4,494	0.0%	176,500	12/31/2023
2023 Q3	11/13/2023	2,637	0.0%	189,733	9/30/2023
2023 Q2	8/11/2023	5,231	0.0%	176,528	6/30/2023
2023 Q1	5/15/2023	5,231	0.0%	176,528	3/31/2023
2022 Q4	2/14/2023	4,482	0.0%	179,567	12/31/2022
2022 Q3	11/14/2022	3,647	0.0%	167,545	9/30/2022
2022 Q2	8/12/2022	3,826	0.0%	194,324	6/30/2022
2022 Q1	5/16/2022	18,208	0.0%	430,243	3/31/2022
2021 Q4	2/14/2022	16,892	0.0%	266,051	12/31/2021
2021 Q3	11/15/2021	15,642	0.0%	266,289	9/30/2021
2021 Q2	8/16/2021	13,679	0.0%	282,039	6/30/2021